Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM10 | O14672 | 20/20 | 0.52 |
| ▸ | MMP2 | P08253 | 17/20 | 0.52 |
| ▸ | MMP3 | P08254 | 7/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 7/20 | 0.42 |
| ▸ | MMP9 | P14780 | 11/20 | 0.35 |
| ▸ | MMP1 | P03956 | 4/20 | 0.34 |
| ▸ | MMP12 | P39900 | 2/20 | 0.34 |
| ▸ | MMP14 | P50281 | 2/20 | 0.34 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.34 |
| ▸ | ADAM33 | Q9BZ11 | 2/20 | 0.34 |
| ▸ | ADAM8 | P78325 | 1/20 | 0.34 |
| ▸ | MMP7 | P09237 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5038481 | 1.00 | ADAM10 (0.52) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL5622074 | 0.91 | ADAM10 (0.44) | ADAM10MMP2MMP3ERBB2 | |
| SCHEMBL5038740 | 0.87 | ADAM10 (0.49) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL5045388 | 0.87 | ADAM10 (0.49) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL5038505 | 0.85 | ADAM10 (0.63) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL5038686 | 0.85 | ADAM10 (0.63) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL3458214 | 0.83 | ADAM10 (0.41) | ADAM10MMP2MMP3 | |
| SCHEMBL4530938 | 0.83 | ADAM10 (0.60) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL4537261 | 0.83 | ADAM10 (0.60) | ADAM10MMP2MMP3ERBB2MMP9 | |
| SCHEMBL5038031 | 0.83 | ADAM10 (0.42) | ADAM10MMP2MMP3ERBB2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1622569-A4 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES | INCYTE CORP (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1622569-A2 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES | Incyte Corporation (US) | 2006-02-08 | — | — | EP | claimed |
| WO-2004096139-A2 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLOPROTEASES | INCYTE CORPORATION (US) | 2004-11-11 | — | — | WO | claimed |
| EP-1622569-A4 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES | INCYTE CORP (US) | 2008-08-27 | — | — | EP | disclosed |
| EP-1622569-A2 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES | Incyte Corporation (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004096139-A2 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLOPROTEASES | INCYTE CORPORATION (US) | 2004-11-11 | — | — | WO | disclosed |